Cubist Systematic Strategies’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Cubist Systematic Strategies’s Portfolio SRRA Stock Details SRRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-20,123	Closed	-$1.11M	–	5051
2022 Q2	$1.11M	Sell	20,123 -25,007	-55%	-$1.31M	0.01%	2406
2022 Q1	$1.45M	Buy	+45,130	New	+$1.29M	0.01%	1751
2019 Q2	–	Sell	-89	Closed	-$6K	–	2642
2019 Q1	$6K	Sell	89 -67	-43%	-$4.3K	﹤0.01%	2203
2018 Q4	$8K	Sell	156 -69	-31%	-$4.41K	﹤0.01%	1991
2018 Q3	$15K	Buy	225 +12	+6%	+$1.09K	﹤0.01%	1805
2018 Q2	$25K	Sell	213 -143	-40%	-$14.3K	﹤0.01%	1699
2018 Q1	$29K	Buy	356 +136	+62%	+$15.4K	﹤0.01%	1737
2017 Q4	$33K	Buy	220 +203	+1,194%	+$19.5K	﹤0.01%	1811
2017 Q3	$1K	Buy	+17	New	+$997	﹤0.01%	1816

Other funds holding SRRA

Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Cubist Systematic Strategies's SRRA Position: Q3 2022 in Review

Cubist Systematic Strategies sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 20,123 shares — an estimated $1.11M sold.

Cubist Systematic Strategies first reported a position in SRRA in Q3 2017 and held it in 9 quarters. The position peaked at $1.45M in Q1 2022. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.

Cubist Systematic Strategies reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Cubist Systematic Strategies sold 20,123 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $1.11M.
Cubist Systematic Strategies first reported a position in Sierra Oncology, Inc. Common Stock in Q3 2017 and held it in 9 quarters.
Cubist Systematic Strategies's Sierra Oncology, Inc. Common Stock position peaked at $1.45M in Q1 2022.
1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.

Based on Cubist Systematic Strategies's 13F filing for Q3 2022, filed 14 Nov 2022.